| Application no. and date | 16745321.6 (espacenet) (Federated) (European Patent Register), 20160719 | | Patent/reg. no. and date | DK/EP 3325444, 20210707 | | Publication date | 20180530 | | Priority no. and date | US 201562194725 P, 20150720 | | EP pub. no. and date |
EP 3325444 20180530 | | Effective date | | | Applicant/owner | Acadia Pharmaceuticals Inc., 12830 El Camino Real, Suite 400
San Diego, CA 92130, US | | Applicant ref. no. | 1588671 | | Inventor | WEBER, Beat, T., Wiesenstrasse 4
CH-4800 Zofingen, CH,
CARLOS, Marlon, 1414 Klamath Drive
Chula Vista, CA 91913, US,
BOUDIER, Andreas, Philipp, Schrennengasse 11
CH-8003 Zurich, CH,
TANDEL, Sagun, 4089 Nobel Drive No. 3
San Diego, CA 92122, US,
OLSSON, Roger, Klagshamnsvagen 99
SE-21838 Bunkeflostrand, SE,
FLEMING, Matthew, J., Untere Bruhlstrasse 4
CH-4800 Zofingen, CH,
HILLGREN, Mikael, Byggmästargatan 11B
75435 Uppsala, SE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | C07D 211/58 (2006.01) | | Title | FREMGANGSMÅDER TIL FREMSTILLING AF N-(4-FLUORBENZYL)-N-(1-METHYLPIPERIDIN-4-YL)-N'-(4-(2-METHYLPROPYLOXY)PHENYLMETHYL)CARBAMID OG DETS TARTRATSALT OG POLYMORF FORM C | | Int. application no. | US2016042933 | | Int. publication no. | WO2017015272 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
